Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Nuffield Department of Population Health researchers nominated for child and adolescent mental health award

Professor Mara Violato and Dr Shuye Yu from the Health Economics Research Centre are part of a multidisciplinary study team that has been nominated for a prestigious Association for Child and Adolescent Mental Health (ACAMH) award.

Study finds tailored exercise programme feasible for adults over 80 with osteoarthritis

A new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study has found that a tailored exercise programme for people aged 80 years and older with hip and/or knee osteoarthritis and other long term health conditions is both practical and acceptable, paving the way for a large clinical trial.

Oxford named best university in the world for a record tenth consecutive year

Oxford University has been world number one in the Times Higher Education World University Rankings since 2017 - the longest time any university has held the position in the 21 annual editions of the rankings.

Prostate specific antigen (PSA) testing patterns in England raise concerns about overtesting

Study of 10 million men finds many are having prostate cancer tests more frequently than recommended. Research published in The BMJ reveals significant variations in PSA testing across England, raising concerns about overtesting.

Nuffield Department of Medicine scientists receive funding for children’s cancer vaccine development

A new partnership between Alice’s Arc, the Centre for Immuno-Oncology in the Nuffield Department of Medicine and the Sir William Dunn School of Pathology will pioneer the development of a bespoke mRNA vaccine to improve treatment outcomes for children with rhabdomyosarcoma, a rare and aggressive form of soft tissue cancer.